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Abstract
It is well accepted that aging and HIV infection are associated with quantitative and function-
al changes of CMV-specific T cell responses. We studied here the expression of Mip-1β
and the T cell maturation marker CD27 within CMVpp65-specific CD4+ and CD8+ T cells in
relation to age, HIV and active Tuberculosis (TB) co-infection in a cohort of Tanzanian vol-
unteers (16 years of age, n = 108 and18 years, n = 79). Independent of HIV co-infection,
IFNγ+ CMVpp65-specific CD4+ T cell frequencies increased with age. In adults, HIV co-in-
fection further increased the frequencies of these cells. A high capacity for Mip-1β produc-
tion together with a CD27low phenotype was characteristic for these cells in children and
adults. Interestingly, in addition to HIV co-infection active TB disease was linked to further
down regulation of CD27 and increased capacity of Mip-1β production in CMVpp65-specific
CD4+ T cells. These phenotypic and functional changes of CMVpp65-specific CD4 T cells
observed during HIV infection and active TB could be associated with increased CMV
reactivation rates.
Introduction
Primary cytomegalovirus (CMV) infection occurs often at birth or during adolescence with
prolonged viral shedding into the urine and saliva that can persist for years. In adults, primary
CMV infection is typically controlled within 6 months [1]. Thereafter, CMV persists lifelong in
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a state of clinical latency [2,3]. The CMV-specific adaptive immune response efficiently sup-
presses overt viral replication and prevents viral shedding for decades. Aging is notably associ-
ated with accumulation of high frequencies of oligoclonal CMV-specific CD8+ T cells [4]. In
late-stage AIDS patients (CD4 counts<50/μl), CMV infection can cause disseminated or local-
ized end-organ disease [5]. CMV-specific CD4+ T cell responses appear to be crucial for CMV
control in murine models and in humans [6],[4]. In adults, these CMV-specific CD4+ T cells
are characterized by: (i) highly differentiated CD27-/CCR7- effector memory phenotype; (ii)
propensity to secrete the CCR5 ligand Mip-1β and (iii) high cytolytic activity against CMV in-
fected cells and these characteristics differ from HIV- or Vaccinia virus-specific CD4+ T cells
[7].
CMV-specific CD4+ T cells are relatively resistant to HIV infection and HIV mediated de-
pletion [8], [9], [10], and this has been linked to their propensity to secrete Mip-1β. Mip-1β has
also been connected to the expression of the immune senescence marker CD57 [11]. However,
the underlying immunological mechanisms that “imprint” this particular phenotype and high
capacity for Mip-1βproduction are unclear. Recent or on-going antigen exposure causes differ-
entiation of pathogen-specific CD4+ T cells into CD27- effector memory phenotype and can in-
flict functional changes [7,10,12–14]. One factor contributing to an increased capacity to
produce Mip-1β could be recurrent or transient, subclinical reactivation of CMV throughout
life. To address this hypothesis, we studied cell frequencies, Mip-1β production and CD27 ex-
pression of CMV-specific CD4+ and CD8+ T cells in children, adolescence and adults in rela-
tion to age, HIV and active tuberculosis infection in individuals from Tanzania, where CMV
infection prevalence reaches up to 100% in adults [15].
Results and Discussion
Detection of CMV-specific T cell responses using polychromatic flow cytometry after in vitro
stimulation is a reliable marker for determining the CMV infection status in children [16].
CMVpp65-specific CD4+ and CD8+ T cell responses were characterized in a Tanzanian cohort
(n = 187) encompassing children (<10 years of age, n = 79), adolescents (10–16 years of age,
n = 29) and adults (>18 years of age, n = 79). This Tanzanian cohort is described in greater de-
tail [17]. The gating strategy and representative flow cytometry plots are shown in Fig 1. Study
subjects were stratified according to age and their HIV and TB co-infection status. In the ab-
sence of a reliable test for definite childhood TB classification, HIV- paediatric TB suspects in-
cluded culture-confirmed TB (n = 14) and uncertain TB classification (n = 16). HIV+
paediatric TB suspects (n = 31) included culture confirmed TB (n = 4), and 13 subjects with
uncertain TB classification (n = 13). In 46 HIV- and 13 HIV+ children an alternative diagnosis
could be established after 5 months of clinical follow-up excluding active TB [17].
As expected, the prevalence of CMVpp65-specific T cell responses increased with age (Fig
2A). In the HIV- group, CMVpp65-specific T cell responses were detectable in 48.5% (16 of
33) of children<5 years of age, in 77.3% (17 of 22, Fig 2B) of children between 5 and 10 years,
in 81% (17 of 21) of adolescents (10–16 years) and 96% (48 of 50) of adults (Fig 2A,
P<0.0001). In the HIV+/AIDS group, CMVpp65-specific T cell responses were detectable in
70% (7 of 10) of children<5 years of age, in 92.8% (13 of 14) of children (5–10 years), in 87.5%
(7 of 8) of adolescents (10–16 years) and 89.7% (26 of 29) of adults. Interestingly, in children
<10 years of age, HIV infection was associated with an increased prevalence of CMVpp65-spe-
cific T cell responses (p = 0.067). These data suggest that within the studied Tanzanian popula-
tion, CMV infections are mostly acquired within the first 10 years of life with HIV infection
being a potential risk factor for early acquisition of CMV infection. When compared to West-
African populations, CMV infection seems to be acquired at an older age where by the age of
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Fig 1. Gating strategies and CMV responses evaluation. A) Morphological and CDmarker expression gating strategy of CD4 and CD8 T cell. B)
Representative CD4 and CD8 T cell IFNγ response from a significant responder. C) Gating strategy for the CD27MFI Fold Change calculation of IFNγ
producing cells compared to all CD4 or CD8 T cells. D) Gating strategy for the determination of IFNγ producing cells that were also positive for
Mip1β production.
doi:10.1371/journal.pone.0126716.g001
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12 months close to 100% of children showed serological evidence of CMV infection or had re-
leased CMV DNA in urine [18,19].
CD4 T cell responses targeting purified protein derivatives (PPD) followed a similar trend
(data not shown), indicating that detection of Mycobacteria-specific T cells in adolescents and
adults are not a consequence of BCG vaccination during early infancy (BCG vaccination cover-
age for patients<18 years was 97.7% (43 of 44, unknown status n = 1). These findings are con-
sistent with the disappearance of circulating Mycobacteria-specific CD4 T cell responses upon
BCG vaccination within one year following vaccination [20].
Next, we compared the contribution of CD4+ or CD8+ T cells to the CMV-specific T cell re-
sponses in children (<10 years) and adults (>18 years). A high number of children (36.4% for
HIV- and 45% for HIV+) mounted CMV responses exclusively within the CD8+ T cell subset
irrespective of their HIV status. In HIV+ individuals, the difference between children and
adults reached statistical significance with more individuals having both CD4+ and CD8+
CMV-specific T cell responses in the adult HIV+ group (Fig 2B, P = 0.037).
Adults showed increased frequencies of CMVpp65-specific CD4+ T cells compared to chil-
dren<10 years regardless of their HIV infection status (Fig 3A, HIV-: median 0.15% vs. 0.06%,
P = 0.0004; HIV+: median 0.26 vs. 0.07%, P = 0.002). A higher frequency of CMVpp65-specific
CD8+ T cell responses in adults was also observed, particularly within the context of HIV
Fig 2. CMVpp65-specific T cell responses in relation to age and HIV infection status. (A) Frequency of
subjects with or without CMVpp65-specific T cell responses (CD4+ or CD8+) is shown stratified by age group
and HIV status. B) The frequency of subjects with CMVpp65-specific T cell responses distributed within the
CD4+ and/or CD8+ T cell compartment is shown after stratification by HIV status. The number of subjects in
each group is indicated within brackets. CMVpp65-specific T cell responses were considered positive if the
frequency of IFNγ+ T cells was 2-fold above the negative control and at least 0.05% of the parent population.
Statistical analysis was performed using the chi-square test for trend (A) and chi-square test (B).
doi:10.1371/journal.pone.0126716.g002
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infection (Fig 3C, median 0.15% vs. 0.37%, P = 0.017) [4,21]. Absolute counts of
CMVpp65-specific CD4+ T cells no longer increased with age and were significantly affected
by HIV co-infection in children and adults (Fig 3B, P = 0.045 and P = 0.0276 respectively). In
line with previous reports showing age related differences in the proportion of IFNγ+ T cells in
response to SEB stimulation [22–24], we also observed significantly reduced frequencies and
absolute counts of IFNγ+-CD4+ T cell responses after SEB stimulation in children (Fig 4). This
could reflect the higher proportion of naïve T cells in children, that cannot express IFNγ [25]
and might also be linked to IFNγ promoter hyper methylation of naïve T cells in infants [26].
Importantly, the proportion of responders with CMVpp65-specific CD4+ T cells was similar
between HIV+ (12 of 19, 63.1%) and HIV- (11 of 20, 55%) children (P = 0.53). This demon-
strates that CMV-specific CD4+ T cells persisted in children<10 years of age during concur-
rent HIV infection as described previously for adults [10,27], even though absolute numbers of
CMVpp65-specific CD4+ T cells were reduced in HIV+ adults and children (Fig 3B). Relative
resistance of CMV-specific CD4+ T cells to HIV-induced depletion has been linked to their
high capacity for Mip-1β secretion [7] together with their mature phenotype, characterized by
a high proportion of cells expressing the senescence marker CD57 [28]. Expression of CD57 on
Fig 3. Frequencies and absolute counts of IFNγ+-CMVpp65–specific CD4+ or CD8+ T cell in children below 10 years of age and adults. Scatter-plots
depicting A) the frequencies or absolute counts of CMV specific IFNγ+-CD4+ T cells s and C) frequencies of CMV specific IFNγ+-CD8+ T cells in the two-age
groups and according to HIV status.
doi:10.1371/journal.pone.0126716.g003
Fig 4. Frequencies and absolute counts of IFNγ+-SEB–specific CD4+ or CD8+ T cell in children below 10 years of age and adults. Scatter-plots
depicting A) the frequencies or B) absolute counts of SEB specific IFNγ+-CD4+ T cells s and C) frequencies of SEB specific IFNγ+-CD8+ T cells in the two-
age groups and according to HIV status.
doi:10.1371/journal.pone.0126716.g004
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CMV-specific CD4+ T cells correlates with an increased capacity to produce Mip-1β [10]. We
thus wanted to determine whether the capacity for Mip-1β production is associated with aging
in our cohort. There was no linear relationship between age and capacity for Mip-1βproduction
in IFNγ+ CMV-specific CD4+ T cells in HIV- subjects (data not shown). Both HIV- adults and
children had IFNγ+ CMV-specific CD4+ T cells characterized by a CD27low phenotype
(P = 0.332) and a similar capacity to co-express Mip-1β (median 32.4% v 50%, P = 0.372, Fig 5
and Fig 1C and 1D for gating strategy details). A previous study reported a predominance of
undifferentiated CD27+ CMV-specific CD4 T cells in infants [29] and an unusual immature
CD27 phenotype predominance in adults contrasting with several other reports [10],[30],[31].
Differences in study population or methodology could account for this discrepancy. Interest-
ingly, down regulation of CD27 and increased frequencies of Mip-1β co-producing CD4+ T
cells occurred in adults with active TB (P = 0.036 and 0.0596) and particularly in those co-in-
fected with HIV (P = 0.008 and 0.002). This result demonstrates to our knowledge for the first
time that active TB infection alone is associated with phenotypic and functional changes in
CMV-specific CD4+ T cell response in adults. A significant impact of HIV and active
Fig 5. CD27 and Mip-1β expression of CMV specific IFNγ producing CD4 T cell responses are influenced by HIV as well as tuberculosis co-
infection in adults. Scatter-plots illustrating (A) the CD27 MFI fold-change to all CD4+ T cells and B) the proportion of cells producing Mip-1β of CMV specific
IFNγ+-CD4+ T cell in patients under 10 or over 18 years old and according to HIV and TB infection status.
doi:10.1371/journal.pone.0126716.g005
Fig 6. CD27 and Mip-1β expression of CMV specific IFNγ producing CD8 T cell responses are not significantly influenced by HIV as well as
tuberculosis co-infection in adults. Scatter-plots illustrating (A) the CD27MFI fold-change to all CD8+ T cells and B) the proportion of cells producing Mip-
1β of CMV specific IFNγ+-CD8+ T cell in patients under 10 or over 18 years old and according to HIV and TB infection status.
doi:10.1371/journal.pone.0126716.g006
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tuberculosis on the CD27 phenotype of CMV-specific CD8+ T cells was not observed (Fig 6A
and 6B). Based on these results, we hypothesis that that the CMV virus might reactivate during
active TB, particularly so in HIV+ subjects – driving further antigen-driven CMV-specific cel-
lular maturation and increased Mip-1β production [9,10]. This is supported by the known he-
matopoietic niche for latent CMV viruses which reactivate upon differentiation of myeloid
precursor into tissue macrophages [32]. Cellular recruitment including monocyte-derived
macrophages is essential for the granuloma formation that typifies tuberculosis pathogenesis
[33]. Similar changes were not detected in HIV+ children. However, the number of children in-
cluded in the analyses and the fact that all enrolled children were TB suspects limits the validity
of this finding.
Conclusion
We show that CMVpp65-specific T cell responses are detectable in the peripheral blood of
most Tanzanian children indicating that acquisition of CMV infection typically occurs during
infancy and early childhood with HIV being a risk factor. In comparison to adults, there was
an increased proportion of CD8+ T cells participating in the response and this was particularly
apparent in HIV+ children. In children, CMVpp65-specific CD4+ T cells had a mature
CD27low effector memory phenotype and a high capacity for Mip-1β production similar to
those detected in adults, and there was no apparent effect of HIV co-infection. Despite some
limitations of the current study, such as the hospital based inclusion of children, our results
suggest that the high capacity for Mip-1βproduction of CMV-specific CD4+ T cells is indepen-
dent of age. Importantly, we observed for the first time that active TB impacts on the CMV-
specific CD4+ T cell phenotype. This may reflect recent CMV reactivation and would indicate




The study was conducted at two Tanzanian research sites—the NIMR-Mbeya Medical Re-
search Center, Mbeya, and the Ifakara Health Institute, Bagamoyo. The Institutional Review
Board of the Ifakara Health Institute, the Mbeya Medical Research and Ethics Committee, and
the Medical Research Coordinating Committee of Tanzania approved the study protocols. We
obtained written informed consents from adults or for children from a literate parent or legal
guardian who participated in the TB child study [17] or the Worm HIV Interaction study
(adults only) [34].
Study subjects and blood sampling
Children older than 7 years provided assent for participation. Children and adolescents (16
years old) were enrolled in the context of clinical consultation for illnesses that resemble active
tuberculosis. HIV-/TB- healthy controls andMTB culture-confirmed TB cases were enrolled into
the adult group (18 years old). Blood was collected into Vacuette CPDA tubes and PBMC isola-
tion performed using Ficoll gradient centrifugation (Leucosep, Greiner Bio-One GmbH) before
cryopreservation in fetal calf serum containing 10% DMSOwithin 6h of phlebotomy.
Reagents
Complete Medium (CM) (RPMI 1640 W/Glutamax and Penicillin-Streptomycin (Gibco, Invi-
trogen), 100μg/ml, 10% heat-inactivated FCS (FBS Gold A11-151, PAA Germany). Anti-
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CD4-PerCP Cy5.5 (Oct4) and HLA-DR Pe-Cy7 (LN3) were purchased from eBioscience. Anti-
CD8 Horizon V500 (RPA-T8); anti-CD27-APC H7 (M-T271); anti-CD3-Pac Blue (UCHT-1);
anti-IFNγ-FITC (B27); anti-CD154-APC (TRAP1); anti-Mip-1β-PE (D21-1351); CST and
compensation beads were obtained from BD Pharmingen.
Intracellular cytokine staining
PBMC were thawed and washed twice in CM containing benzonase (Novagen, 25KU, 1/5000
V/V). Viability was assessed using trypan blue exclusion after a resting period of 2–6 hours at
37°C in complete medium. Cells were stimulated for 12h to 16h in complete medium contain-
ing Brefeldin A (Sigma-Aldrich, 5ug/ml) and CD28/CD49d antibodies (Pharmingen, 1ug/ml)
with CMVpp65 peptide set (JPT Peptide Technologies, 2ug/ml), Staphylococcal Enterotoxin B
(Sigma-Aldrich, 0.8ug/ml) or nothing as a negative control. Intracellular cytokine staining was
performed using a standard staining protocol [10]. Acquisition of cells was performed on BD
FACS Canto2 (NIMR-MMRC, Mbeya) or BD Fortessa (IHI-BRTC, Bagamoyo). Instruments
were calibrated before each run using BD Cytometer Setup and Tracking Beads according to
manufacturer’s recommendations. Data were analysed using FlowJo 9.X (Tree Star). T cell re-
sponses were considered positive, if the frequency of IFNγ+ cells was above 0.05% of the parent
population and>2-fold the background frequency in the unstimulated control. GraphPad
Prism (San Diego, CA, USA), version 4.03, was used for statistical analysis. Anonymized pa-
tient characteristics and the respective flow cytometry data statistics are provided as S1 Table.
Supporting Information
S1 Table. Participant level data; anonymized patient characteristics and respective flow cy-
tometry data statistics. Column legends: A) Tuberculosis classification (see [17]); B) Age
(years); C) HIV status (1: positive, 2: negative); D) CD4 cell counts per μl of blood; E) CD4 T
cell percentages observed after PBMC stimulation; F) Signif: CD4 T cell response to CMVpp65
stimulation passed threshold for significance (see methods), NS: Not significant; G to I) Per-
centages of CD4 T cell producing one or both of the indicated cytokine(s) observed after
PBMC stimulation with CMVpp65 (γ: IFN-γ, MIP: Mip-1β); J) Proportion of CD4 T cell pro-
ducing Mip-1β that also produced IFN-γ; K) CD27 MFI Fold Change of IFNγ producing cells
compared to all CD4 T cells (see Fig 1 for gating strategy); L to Q) as for F to K) but for CD8 T
cell responses to CMVpp65 PBMC stimulation.
(XLSX)
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